Fino ad oggi la raccolta di informazioni sugli effetti collaterali of drugs was through a network of doctors and pharmacists who sent paper models the ministerial structures who used to collect and process data.
But in the era of Web 2.0 also Pharmacovigilance is about to become Social.
two important news:
- direct participation of patients in reporting adverse events;
- use the Web to relay signals elle d € ;
Everything is an initiative of the European Parliament has recently approved a new warning system.
soon will be the same patients to report directly, via the web, or unwanted side effects.
Many physicians have always raised doubts that the current detection system could underestimate or overestimate in most cases (in the case of newly introduced drugs) the actual frequency with which you experience side effects.
Linda McAvan According to the rapporteur, MEP British group of the Progressive Socialist Democrats, it is clear that with the help of 500 millions of people involved, you can have a more clear and precise picture of the tolerability of drugs on the market.
To achieve the European network will be created national sites are linked to a European portal.
They will have the function of disseminating information about drugs ee possible adverse effects and should include the assessment relazionidi and summaries of product characteristics and package leaflets.
The database "Eudravigilance" will soon be the point of collection and analysis of all pharmacovigilance information from pharmaceutical companies and national authorities.
The operational phase will start in 18 months when the new legislation will come into force in member countries.
0 comments:
Post a Comment